Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

NMPA Approves Mabwell's New Drug Application for 8MW0511 Injection

Wednesday, December 20, 2023

Mabwell is an innovative biopharmaceutical company boasting a comprehensive industry chain Recently the National Medical Products Administration accepted the new drug application for its recombinant human serum albuminhuman

RNAimmune Secures FDA Approval for Investigational New Drug Application of mRNA-Based Respiratory Syncytial Virus Vaccine RV-1770

Tuesday, December 19, 2023

Sirnaomics Ltd a prominent biopharmaceutical company specializing in advanced RNAi therapeutics has recently disclosed a pivotal development through its subsidiary RNAimmune Inc

FDA Approves Investigational New Drug Status for RSV mRNA Vaccine Developed by RNAimmune, in Collaboration with Innoforce

Tuesday, December 19, 2023

RNAimmune Inc together with its partner Innoforce has obtained IND clearance from the US Food and Drug Administration for its RV Respiratory Syncytial Virus RSV mRNA vaccine Innoforce extends its congratulations

FDA Approves ALYGLO™ 10% for Adult Primary Immunodeficiency

Monday, December 18, 2023

GC Biopharma Corp has received approval from the US Food and Drug Administration for ALYGLO Liquid formerly known as GC designed for treating adult patients aged and above with primary humoral immunodeficiency

GeneQuantum and BioMap Form Strategic Collaboration to Advance Next-Generation ADC Therapeutics

Monday, December 18, 2023

GeneQuantum Healthcare a prominent player in ADC new drug development with a focus on innovative bioconjugation technologies has recently entered into a strategic collaboration with BioMap

Nona Biosciences and Pfizer Have Entered Into a Worldwide License Agreement for HBM9033, an Antibody-drug Conjugate (ADC) Targeting MSLN

Friday, December 15, 2023

Nona Biosciences a global biotechnology company specializing in a comprehensive Idea to IND solution covering target validation antibody discovery and preclinical research

Abelzeta Announces a Modification to Its Worldwide Collaboration and Licensing Agreement With Janssen, Now Extending to Include China

Friday, December 15, 2023

AbelZeta Pharma Inc a global clinicalstage biopharmaceutical company specializing in the development of innovative cellbased therapeutic products has recently made adjustments to its collaboration

Abbisko Therapeutics Announces That Its CSF-1R Inhibitor Pimicotinib (ABSK021) Has Been Granted Fast Track Designation by the U.S. FDA

Thursday, December 14, 2023

Abbisko Therapeutics Co Ltd has announced that the US FDA has granted fast track designation for its CSFR inhibitor pimicotinib in the treatment of tenosynovial giant cell tumor

LEQEMBI® Scheduled for Launch in Japan for Alzheimer's Disease Treatment on December 20th

Wednesday, December 13, 2023

Eisai the collaborator of BioArctic AB has announced the forthcoming launch of LEQEMBI in Japan on December This follows its inclusion in the price listing on the Japan

NMPA Approves New Drug Application for Henlius Anti-PD-1 mAb Serplulimab Combined with Chemotherapy in First-Line non-squamous NSCLC Treatment

Wednesday, December 13, 2023

Shanghai Henlius Biotech Inc has recently disclosed that the National Medical Products Administration has accepted the New Drug Application for a new indication of HANSIZHUANG